Search Orphan Drug Designations and Approvals
-
Generic Name: | deoxythymidine monophosphate and deoxycytidine monophosphate |
---|---|
Date Designated: | 07/07/2016 |
Orphan Designation: | Treatment of thymidine kinase 2 deficiency. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
UCB, Inc. 1950 Lake Park Drive, Bldg 2100 Smyrna, Georgia 30080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-